Skeletal Morbidity in Children and Adolescents during and following Cancer Therapy
- 27 November 2018
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 91 (2) , 137-151
Abstract
Skeletal abnormalities are common in children and adolescents diagnosed and treated for a malignancy. The spectrum ranges from mild pain to debilitating osteonecrosis and fractures. In this review, we summarize the impact of cancer therapy on the developing skeleton, provide an update on therapeutic strategies for prevention and treatment, and discuss the most recent advances in musculoskeletal research. Early recognition of skeletal abnormalities and strategies to optimize bone health are essential to prevent long-term skeletal sequelae and diminished quality of life in childhood cancer survivors.Keywords
This publication has 129 references indexed in Scilit:
- Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood CancerJAMA, 2013
- Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphomaBlood Research, 2013
- Bone density in post‐pubertal adolescent survivors of childhood brain tumorsPediatric Blood & Cancer, 2011
- Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemiaBlood, 2011
- Effects of Sex, Race, and Puberty on Cortical Bone and the Functional Muscle Bone Unit in Children, Adolescents, and Young AdultsThe Journal of Clinical Endocrinology & Metabolism, 2010
- Height Adjustment in Assessing Dual Energy X-Ray Absorptiometry Measurements of Bone Mass and Density in ChildrenThe Journal of Clinical Endocrinology & Metabolism, 2010
- Predictors of avascular necrosis of bone in long‐term survivors of hematopoietic cell transplantationCancer, 2009
- Bone density, structure, and strength in juvenile idiopathic arthritis: Importance of disease severity and muscle deficitsArthritis & Rheumatism, 2008
- A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology GroupBlood, 2008
- Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemiaThe Journal of Pediatrics, 1995